Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
Purchase agreement with ViewRay will make state-of-the art precision radiation therapy available in China
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Subscribe To Our Newsletter & Stay Updated
